Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 4
1952 3
1953 6
1954 4
1955 3
1956 5
1957 6
1958 11
1959 7
1960 7
1961 5
1962 17
1963 29
1964 92
1965 51
1966 42
1967 66
1968 84
1969 75
1970 96
1971 110
1972 126
1973 137
1974 160
1975 172
1976 149
1977 139
1978 145
1979 166
1980 162
1981 167
1982 182
1983 185
1984 204
1985 196
1986 214
1987 244
1988 225
1989 240
1990 260
1991 274
1992 301
1993 358
1994 358
1995 394
1996 429
1997 454
1998 540
1999 542
2000 597
2001 607
2002 590
2003 803
2004 831
2005 850
2006 827
2007 925
2008 981
2009 1045
2010 1215
2011 1292
2012 1529
2013 1739
2014 1774
2015 1786
2016 1824
2017 1698
2018 1602
2019 1507
2020 1537
2021 1507
2022 1283
2023 1065
2024 386

Text availability

Article attribute

Article type

Publication date

Search Results

34,568 results

Results by year

Filters applied: . Clear all
Page 1
Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.
Holford NH. Holford NH. Clin Pharmacokinet. 1986 Nov-Dec;11(6):483-504. doi: 10.2165/00003088-198611060-00005. Clin Pharmacokinet. 1986. PMID: 3542339 Review.
Prothrombin complex synthesis is inhibited 50% at a warfarin concentration of about 1.5 mg/L. Warfarin concentrations associated with therapeutic anticoagulation are of similar magnitude. ...On average it will take 3 days for the anticoagulant effect of warfarin …
Prothrombin complex synthesis is inhibited 50% at a warfarin concentration of about 1.5 mg/L. Warfarin concentrations associat …
Warfarin pharmacogenomics.
Cavallari LH, Limdi NA. Cavallari LH, et al. Curr Opin Mol Ther. 2009 Jun;11(3):243-51. Curr Opin Mol Ther. 2009. PMID: 19479657 Review.
Warfarin therapy is complicated by a narrow therapeutic index and substantial interpatient variability in dose response. ...The results of ongoing or future multicenter clinical trials are expected to clarify the role of pharmacogenomics in the management of warfarin …
Warfarin therapy is complicated by a narrow therapeutic index and substantial interpatient variability in dose response. ...The resul …
Warfarin interactions with medicinal herbs.
Milić N, Milosević N, Golocorbin Kon S, Bozić T, Abenavoli L, Borrelli F. Milić N, et al. Nat Prod Commun. 2014 Aug;9(8):1211-6. Nat Prod Commun. 2014. PMID: 25233607 Review.
The interactions between warfarin and medicinal herbs described in the literature have been summarized in this paper relying on Medline database (via PubMed) using the key words: warfarin, herbal supplements and interactions. ...Some of the interactions between w …
The interactions between warfarin and medicinal herbs described in the literature have been summarized in this paper relying on Medli …
Warfarin therapy. 2.
Deykin D. Deykin D. N Engl J Med. 1970 Oct 8;283(15):801-3. doi: 10.1056/NEJM197010082831508. N Engl J Med. 1970. PMID: 4917271 Review. No abstract available.
Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis.
Chai-Adisaksopha C, Iorio A, Hillis C, Siegal D, Witt DM, Schulman S, Crowther M. Chai-Adisaksopha C, et al. Thromb Res. 2017 Dec;160:97-104. doi: 10.1016/j.thromres.2017.11.001. Epub 2017 Nov 11. Thromb Res. 2017. PMID: 29136562 Review.
BACKGROUND: This study aims to assess the effect of warfarin resumption in patients who experienced warfarin-associated intracranial hemorrhage (ICH). ...CONCLUSION: The study suggests that warfarin resumption is associated with significant reduction in ische …
BACKGROUND: This study aims to assess the effect of warfarin resumption in patients who experienced warfarin-associated intrac …
Warfarin-rifampicin interaction.
Fox P. Fox P. Med J Aust. 1982 Jan 23;1(2):60. doi: 10.5694/j.1326-5377.1982.tb132151.x. Med J Aust. 1982. PMID: 7070329 No abstract available.
Warfarin Sodium Stability in Oral Formulations.
Dimitrokalli E, Fertaki S, Lykouras M, Kokkinos P, Orkoula M, Kontoyannis C. Dimitrokalli E, et al. Molecules. 2021 Nov 1;26(21):6631. doi: 10.3390/molecules26216631. Molecules. 2021. PMID: 34771040 Free PMC article.
Warfarin, not its sodium salt, was identified as the undissolved solid existing in the suspension. ...The effect of pH and temperature on warfarin precipitation was also explored....
Warfarin, not its sodium salt, was identified as the undissolved solid existing in the suspension. ...The effect of pH and temperatur …
Pharmacogenomics and warfarin.
Anderson DC Jr. Anderson DC Jr. Am J Health Syst Pharm. 2009 Jan 15;66(2):121. doi: 10.2146/ajhp080635. Am J Health Syst Pharm. 2009. PMID: 19139475 No abstract available.
Initiating warfarin therapy.
Dager WE. Dager WE. Ann Pharmacother. 2003 Jun;37(6):905-8. doi: 10.1345/aph.1D038. Ann Pharmacother. 2003. PMID: 12773083 No abstract available.
Warfarin.
Benya TJ, Adler DS, Bates TR. Benya TJ, et al. J Am Pharm Assoc. 1976 May;16(5):271-4. J Am Pharm Assoc. 1976. PMID: 1270740 No abstract available.
34,568 results
You have reached the last available page of results. Please see the User Guide for more information.